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STUDY OF THE baiG GENE IN BILE ACID 7a-DEHYDR0XYLATING BACTERIA
Michael R. David May, 1999 38 Pages
Directed by: Kinchel C. Doerner, Larry P. Elliott, and Kenneth M. Crawford
Department of Biology Western Kentucky University
Recently, intestinal bile acid 7a-dehydroxylating bacteria have been implicated in
cholesterol gallstone disease. Eubacterium sp. strain V.P.I. 12708, a bile acid 7a-
dehydroxylating bacteria, contains multiple bile acid inducible (bai) genes which are located
on a large bai operon. Genes of this operon encode the enzymes responsible for bile acid
7a-dehydroxylation. The baiG gene encodes a bile acid transporter in Eubacterium sp.
strain V.P.I. 12708. Utilizing the polymerase chain reaction I determined the presence or
absence of baiG-like genes in six bile acid 7a-dehydroxylating strains: Clostridium sp. strain
TN-271, Eubacterium sp. strain 1-10, Clostridium bifermentans strain 1-55, Clostridium
sordellii strain Y67, Clostridium sp. strain HD-17, and Clostridium sp. strain TO-931.
Results showed amplification in two of the bacterial strains at the predicted DNA fragment
size. Partial DNA sequence analysis of the amplified baiG-like gene fragments revealed 96-
97% homology with the baiG gene of Eubacterium sp. strain V.P.I. 12708. These data
suggest that baiG-like genes are present in Clostridium sp. strain TN-271 and Eubacterium
sp. strain I-10.
I. INTRODUCTION
Primary bile acids, cholic acid and chenodeoxycholic acid, are C-24 steroids that
are synthesized from cholesterol in the liver, conjugated to either glycine or taurine, (28)
secreted into the bile and stored in the gall bladder. After the ingestion of a fatty meal, the
gall bladder releases the bile into the small intestine where bile acids function as biological
detergents by aiding in the absorption of dietary lipids and lipid soluble vitamins (28). Bile
acids are actively reabsorbed through the ileal wall and returned to the liver via hepatic
portal blood circulation and re-secreted into the bile (28). Approximately 5% of the primary
bile acids escape ileal absorption and enter into the large intestine and are exposed to the
indigenous intestinal microflora. Microorganisms capable of bile acid modification
compose only a small percentage of the intestinal microflora. These modifications include
hydrolysis of the amide bond of conjugated bile acids, oxidation and/or reduction of hydroxy
moieties, and reductive 7-dehydroxylation thereby generating secondary bile acids (16) such
as deoxycholic acid (DCA) and lithocholic acid. Secondary bile acids are passively
absorbed through the colon wall, returned to the liver via the portal blood, and accumulate
in the circulating pool of bile acids (28).
Quantitatively, the most important physiological transformation of primary bile acids
is 7oc-dehydroxylation, which is the conversion of the primary bile acids, cholic acid and
chenodeoxycholic acid to the secondary bile acids, deoxycholic acid (DCA) and lithocholic
acid, respectively (28). The colon contains 103to 105bacteria per gram of intestinal content
that are capable of bile acid 7a-dehydroxylation and constitute less that 0.1% of the total
microbial flora (9,26). All isolated strains that posses bile acid 7a-dehydroxylation activity
are anaerobic, gram positive, rod shaped and belong to the genera Clostridium and
Eubacterium (12, 26, 27).
Bacterial 7a-dehydroxylation of primary bile acids is the only source of deoxycholate
and lithocholate production in the body. Deoxycholate can account up to 40% of the total
bile acid pool in humans (3). Secondary bile acids differ from primary bile acids in several
properties. Secondary bile acids are potent down regulators of de novo hepatic cholesterol,
bile acid biosynthesis (11), and possibly promote colon carcinogenesis (5). Studies have
also shown that elevated levels of DCA in bile are correlated with an increased risk of
cholesterol gallstone disease (21,25). Shoda et al. (25) report that DCA facilitates gallstone
formation by increasing cholesterol secretion into the bile which increases the cholesterol
saturation index. Berr et al. (3) report that population levels of colonic bile acid 7a-
dehydroxylating bacteria indirectly control the re-occurrence of cholesterol gallstones.
3Eubacterium sp. strain V.P.I. 12708 is a well studied bacterial strain that 7a-dehydroxylates
bile acids. This organism possesses a cholic acid-inducible enzyme system which can
dehydroxylate both 7a and 7p-bile acids (30, 31, 32). White et al. (31) report that the 7a-
dehydroxylation reaction is rapid, producing 17 nmol/min mg protein of deoxycholic acid
when cholic acid-induced whole cells of Eubacterium sp. strain V.P.I. 12708 are incubated
with 100 |uM [24-14C] cholic acid. Eubacterium sp. strain V.P.I. 12708 possesses a multi-step
bile acid 7a-dehydroxylation pathway with most of the enzymes encoded in a large bile
acid-inducible (bai) operon (10, 20) (Fig. 1). The complete DNA sequences of baiB, baiC,
baiE, baiA2, baiF, baiH, and baiG have been reported (10, 19, 20, 31). Based on the
characterization of bile acid intermediates and the conversion of these intermediates by
purified enzymes isolated from Eubacterium sp. strain V.P.I. 12708, a pathway for 7a-
dehydroxylation of bile acids has been proposed (Fig. 2) (4, 6,15).
Bile acid 7cc-dehydroxylation is initiated by conjugation of the primary bile acid to
coenzyme A at the C-24 carboxylic acid (17). The bile acid-coenzyme A conjugate is
sequentially oxidized to a 3-oxo (18) and then a 3-oxo-A4bile acid intermediate. Following
a 7a-dehydration step to a 3-oxo-A4'6 intermediate (7), there are three sequential reduction
steps resulting in the final secondary bile acid. Presently, it is unclear what physiological
role 7a-dehydroxylation plays in the intestinal bacterium, but it is proposed that bile acid
7a-dehydroxylation act as an ancillary electron acceptor (14).
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Figure 1. The bai operon from Eubacterium sp. strain V.P.I. 12708.
5Mallonee andHylemon (19) report the cloning, expression, and characterization of
an inducible bile acid transporter from Eubacterium sp. strain V.P.I. 12708. The baiG gene
is 1,433 nucleotides in length and contains an open reading frame capable of encoding a 477
amino acid polypeptide with a calculated molecular weight of 49,964 (19). The BaiG
polypeptide has homology to a major superfamily of transmembrane facilitators (22). This
facilitator superfamily is constructed on alignments and statistical analyses of proteins that
establish homology between these clusters. It is proposed that the members of the major
facilitor superfamily of transporters evolved from a polypeptide that contained six
membrane-spanning regions (a domain), and this polypeptide then combined through
recombination or duplication with a p domain that formed the present groups of
polypeptides with twelve to fourteen membrane spanning regions (5). The greatest
homology that has been found between the baiG gene and members of this family are the
class K and L tetracycline resistance proteins of Bacillus subtilis and Staphylococcus aureus
(23, 24).
Escherichia coli transformed with the cloned baiG gene displays higher than normal
levels of cholic acid and chenodeoxycholic acid uptake. This system also exhibits low levels
of transport of deoxycholic acid, cholylglycine, and 7-oxocholic acid (19). These results
suggest that the primary function of the bile acid-inducible BaiG polypeptide in Eubacterium
sp. strain V.P.I. 12708 is to transport bile acids (19).
S-CoA
Figure 2. The proposed mechanism for 7a-dehydroxylation of primary bile acids in
Eubacterium sp. strain V.P.I. 12708.
7Mallonee and Hylemon (19) also speculate there must be a bile acid export activity
independent of BaiG in Eubacterium sp. strain V.P.I. 12708 to remove the products of the
a-dehydroxylation and 7a-hydroxysteroid dehydrogenase activities, as well as other bile
acids that may accumulate in the cell.
The goal in this research project is to determine the presence or absence of a baiG-Mks, gene
in six bacterial strains capable of 7a-dehydroxylating bile acids. In this study I report the
successful identification and partial sequencing of the 6a/G-like gene in Clostridium sp.
strain TN-271 and Eubacterium sp. strain I-10.
n. MATERIALS AND METHODS
Bacterial strains and culture conditions.
Eubacterium sp. strain V.P.I. 12708 was originally isolated from feces of a colon
cancer patient by R Hammann (Institute fur Medizinische Microbiologie und Immunologie
der Universitat, Bonn, Germany). Clostridium bifermentans strain 1-55 and Clostridium sp.
strain HD-17 were isolated from human feces (12). Clostridium sp. strain TO-931,
Clostridium sp. strain TN-271, Eubacterium sp. strain I-10, and Clostridium sordelli strain
Y-67 were also isolated from human feces. Bile acid 7a-dehydroxylating cultures were
incubated under anaerobic conditions and at 37°C in tryptic soy broth (TSB) (Difco
Laboratories, Detroit, MI) or brain heart infusion (BHI) (Difco Laboratories, Detroit, MI)
supplemented with 2 g fructose per liter. Anaerobic medium was prepared as previously
described in the V.P.I. Anaerobe Laboratory Manual (13). To maintain anaerobic
conditions, the medium was boiled, flushed with nitrogen gas and reduced by the addition
of cysteine-HCL (lg/L). The pH of the anaerobic media was adjusted to 7.1, tubed
anaerobically, and autoclaved at 121°C, 15 psi (pounds per square inch) for 20 minutes.
9E. coli INVaF' cells (Invitrogen Corp., Carlsbad, CA) were propagated in Luria-Bertani (LB)
medium, pH 7.1 (10 g Bacto-tryptone, 5g Bacto-yeast extract, and 5 gNaCl per liter) at 37<C
with orbital shaking (Lab-Line histruments, Inc. Melrose Park, IL.) at 2,000 rpm (revolutions
per minute). LB medium was supplemented with 50 jug/ml ampicillin following
autoclaving. LB plates were prepared by inclusion of 15 g of agar per liter to the LB
medium. Prior to inoculation, 40 ^1 of 40 mg/ml 5-bromo-4-chloro-3-indolyl-(3-d-
galactoside (X-gal) were added to each plate.
Chromosomal DNA isolation, Plasmid isolation and Restriction Digest.
Genomic DNA was isolated utilizing the Qiagen (Chatsworth, CA.) genomic tip
procedure. Cultures of bile acid 7a-dehydroxylating bacteria were inoculated into 10 ml of
TSB and incubated for twenty four hours at 37°C, after which 5 ml of the culture was used
as inoculum into 100 ml of TSB medium and incubated for an additional twenty four hours
at 37°C. Next, 90 mis of the culture was inoculated into 1000 ml of TSB medium and
incubated for twenty four hours at 37°C. Four hours prior to collection penicillin G
(0.1 mg/ml) was added. Cells were collected by centrifugation at 12,000 x g for 20 minutes
at 4°C. Chromosomal DNA was extracted and purified according to the instructions of the
supplier (Qiagen Inc., Chatsworth, CA.). After centrifugation, bacterial cells were lysed with
protease K and RNase A. The lysate was then added to an equilibrated Qiagen genomic-tip
column and allowed to empty by gravity flow. The genomic-tip columns (Qiagen,
Chatsworth, CA.) were washed twice with the appropriate buffers.
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DNA was eluted, precipitated with isopropanol, and centrifuged immediately at 5,000 x g
for 20 minutes at 4<€. The centrifuged pellet was washed with 70% ethanol and centrifuged
at 5,000 x g for 20 minutes at 4°C. The pellet was then air dried for 10 minutes and
resuspended in 200ul of double distilled H p . Chromosomal DNA (2 ug) was digested with
EcoEl at 37°C overnight and subjected to electrophoresis with 1.0% (wt/vol) agarose gels
in IX TAE buffer (Tris-acetate-ethylenediamine tetraacetic acid [EDTA]; 40 mM Tris
acetate, 2 mM EDTA).
For routine plasmid analysis, plasmid DNA was isolated utilizing the Qiagen mini-
prep kit. Bacterial cultures were harvested by centrifugation for 2 minutes at 12,000 x g, and
plasmid DNA was extracted and purified according to the instructions of the supplier
(Qiagen Inc.). After centrifugation, bacterial cells were lysed in 0.2 N NaOH with 10% SDS
(sodium dodecyl sulfate) and RNase A. The lysate was neutralized, adjusted to high-salt
binding conditions by addition of the buffer supplied by the manufacturer and centrifuged
at 12,000 x g. The supernatants were applied to a QIAprep column and centrifuged for
30 s (seconds). The columns were washed twice with the appropriate buffers, and DNA was
eluted by adding 50ul of double distilled H2O, and centrifuged for 1 minute. Purified
plasmids were digested with EcoRI, analyzed by gel electrophoresis using 2% agarose in IX
TAE buffer, and visualized by ethidium bromide staining to determine the presence of the
cloned inserts.
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Polymerase Chain Reaction Amplification and DNA Fragment Isolation.
PCR amplifaction was achieved using the protocol of Wang et al. (29). Cultures of
bile acid 7a-dehydroxylating bacteria were centrifuged at 9,000 x g, washed twice with
phosphate-buffered saline (PBS), and once with water at room temperature at 9,000 x g for
3 minutes. Pellets were resuspended in distilled water and diluted 1/100 (vol/vol) in 1%
Triton X-100, boiled for 5 minutes, and immediately cooled in ice water. Primers were
synthesized by a commercial supplier (The Great American Gene Company, Ramona, CA.)
and designed to amplify bases 1 through 364 of the baiG gene from Eubacterium sp. strain
V.P.I. 12708. The primer set is: 5'-TCAGTTTGTTCCTGTGCATCCC-3' (forward 1) and
5'-CGTCTTTGGCTCTTTCTTATCTGC-3' (reverse 1). The permalized bacterial cells
(lOul) from each strain were added to the reaction mixture (90ul). The reaction mixture
contained a final concentration of 20/JVI each primer, 1.25 mM each deoxynucleoside
triphosphate (dGTP, dCTP, dATP, and dTTP), IX PCR buffer (Perkin Elmer, Branchburg,
NJ.), and 0.5 U of Taq polymerase. PCR amplification was performed in a Perkin Elmer
GeneAmp PCR System 2400 (Foster City, CA). The PCR cycling protocol was one cycle
at 94°C for 120 s, 35 cycles at 94°C for 30 s, 50°C for 30 s and 74°C for 35 s, and lastly one
cycle at 74°C for 35 s and 45°C for 2 s. Samples were held at 4°C until collected. Following
PCR, the samples (25 ul) were examined for DNA inserts of the predicted size by agarose
gel electrophoresis procedures using 2.0% (wt/vol) agarose gels.
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Fragments corresponding to the expected size were excised and purified with the GeneClean
kit (Bio 101, Vista, CA.).
Cloning and Transformation of DNA Fragments.
The DNA fragments from PCR amplification were cloned into the vector pCR 2.1
(Invitrogen, Carlsbad, CA.). The ligation mixture contained 1/^ 1 PCR (25 ng) product and
9 iA ligation reaction mixture which contained lx ligation buffer (6 mM Tris-HCl, 6 mM
MgCl2,5 mM NaCl, 0.1 mg/ml bovine serum albumin, 7 mM P-mercaptoethanol, 0.1 mM
ATP, 2 mM dithiothreitol, and 1 mM spermidine), T4 DNA ligase (4.0 Weiss units/ul), and
the pCR 2.1 vector. Competent E. coli INVaF' cells (Invitrogen, Carlsbad CA) were
transformed as described by the manufacturer. Transformed E.coli INVaF' cells
(Invitrogen, Carlsbad CA) were plated on LB plates containing ampicillin (50 ug/ml) and
X-Gal (40 ul of 40 mg/ml) and incubated at 37°C overnight. White colonies were selected
to be re-streaked for isolation. White colonies were selected because a DNA insert will
disrupt the lacZ gene which is present in the vector, which prevents 6-galactosidase
expression and the cleavage of X-Gal. If a DNA insert is not present, 13-galactosidase will
be expressed from the lacZ gene which cleaves X-Gal causing the colonies to appear blue.
Isolated colonies were picked and inoculated into 5 ml of LB broth containing ampicillin (50
ug/ml).
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DNAHybridization.
Chromosomal DNA was isolated and digested with EcoRl and subjected to agarose
gel electrophoresis. To fragment the DNA, gels were treated with 0.25N HC1 for 10
minutes. To denature the DNA, gels were equilibrated in 1.0 M NaCl /0.5 M NaOH twice
for 20 minutes and neutralized in 0.5 M Tris-HCl pH 7.5/1.5M NaCl twice for 20 minutes.
Gels were equilibrated in 10X SSC (1.5 M NaCl, 0.15 M Na3citrate:2H2O, pH 7.0) and
blotted overnight. The only modification to this procedure involved using 10X SSC for the
transfer solution (1). DNA fragments were transferred overnight onto MagnaNT nylon
membranes (Micron Separations, Inc., Westborough, MA) via capillary action and baked for
lhourat80°C(l).
Cloned baiG gene fragments from Clostridium sp. strain TN-271 and Eubacterium
sp. strain I-10 were radioactively labeled utilizing a Bionick Labeling System (Gibco BRL,
Gaithersburg, MD). Unincorporated nucleotides were removed using gel filtration. A
1 ml syringe was closed with glass wool and placed into a 15 ml disposable test tube.
The syringe was filled with swollen Sephadex G-50 which was equilibrated in STE (10 mM
Tris.Cl, pH 7.5, 10 mM NaCl, and 1 mM EDTA) buffer and centrifuged in a clinical
centrifuge. The probe labeling mixture was loaded on top of the column and centrifuged for
6 minutes and the elutant was collected in a 1.5 ml microfuge tube. The nick-translated
probes were boiled for 5 minutes and rapidly cooled on ice prior to addition to the
hybridization solution.
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Hybridization solution consisted of 4X SSC, 50% formamide, 5X Denhardt's solution (1%
ficoll, 1% polyvinyl pyrrolidone, and 1% bovine serum albumin), 1% SDS, and O.lmg/ml
denatured salmon sperm DNA (Sigma Chemical Co. St. Louis, MO). The membrane was
pre-hybridized in a heat sealable bag for 2 hours at 42 V in 7.5 ml of hybridization solution,
prior to addition of the probe. Hybridization took place overnight with shaking at 42°C.
Membranes were washed at room temperature with 2X SSC (5 minutes), 2X SSC with 0.1%
SDS (30 minutes), 0.1X SSC with 0.1% SDS (30 minutes), then 0.1X SSC (30 minutes).
Membranes were then air dried and exposed to Kodak x-ray film at room temperature for
7 days. Films were developed in IX Kodak GBX developer for 4 minutes, washed in water
for 30 s, fixed in IX Kodak GBX fixer for 4 minutes and allowed to wash in water for 5
minutes (Eastman Kodak Company, Rochester, New York).
Sequencing of the PCR products.
DNA templates were sequenced using the fluorescent dideoxy terminator method
of cycle sequencing on a Perkin Elmer, Applied Biosystems Division (PE/ABd) 373A
automated DNA sequencer. The sequencing reactions were performed at the
Macromolecuiar Structure Analysis Facility at the University of Kentucky. The T7 promoter
and Ml 3 reverse promoter present on the vector and flanking the cloned insert were used
as priming sites. The nucleotide sequences were analyzed using the BLAST analysis function
at the National Center for Biotechnology Information (2).
IE. RESULTS
PCR amplification ofbaiG-hke gene fragments:
The amplified baiG-like genes from bacterial strains Clostridium sp. strain TN-271
and Eubaclerium sp. strain I-10 were analyzed with a 2% (wt/vol) agarose gel immediately
following PCR (Fig. 3). Only Clostridium sp. strain TN-271 and Eubacterium sp. strain I-10
yielded an amplified DNA product of the predicted size of 364 bp. As expected, the
negative control which contained DNA from Eubaclerium sp. strain V.P.I. 12708 and only
one primer did not produce an amplified DNA product.
Cloning and screening of baiG-like gene fragments:
Transformation results of the ligation mixture are shown in Table 1. Clostridium sp.
strain TN-271 exhibited 3 white colonies and 8 blue colonies from 100 ul of the ligation
mixture and 3 white and 6 blue colonies from 200 ul of the ligation mixture. Eubacterium
sp. strain 1-10 produced 2 white and 10 blue colonies from 100 ul of ligation mixture and
3 white and 7 blue from 200 ul ligation mixture. From Clostridium sp. strain TN-271 6
white colonies were selected for continued experimentation. From Eubacterium sp. strain
1-10 5 white colonies were selected for continued experimation.
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Figure 3. Agarose gel analysis of amplified DNA fragments. Lanes 1 and 10 contain
molecular weight markers. Lane 2 negative control which contains intact reaction mixture
with Eubacterium sp. strain V.P.I. 12708 DNA expect f, primer is withheld. Lane 3 positive
control which contains intact reaction mixture with Eubacterium sp. strain V.P.I. 12708
DNA. Lanes 4 - 9 contain intact reaction mixtures with DNA from Clostridium sp. strain
TN-271, Eubacterium sp. strain I-10, Clostridium bifermentans strain 1-55, Clostridium
sordellii strain Y67, Clostridium sp. strain HD-17, and Clostridium sp. strain TO-931
respectively.
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Table 1. Results of transformations of E.coli MVaF1 cells with ligation mixture
containing baiG gene fragments when plated onto LB plates containing ampicillin
(50 ng/ml).
Source of baiG-
like
gene fragment
Clostridium sp.
strain
TN-271
Eubacterium sp.
strain
1-10
Plate 1 (100 JJ.1 ligation mixture)
White
Colonies
3
2
Blue
Colonies
8
10
Plate 2 (200 jul ligation mixture)
White
Colonies
3
3
Blue
Colonies
6
7
18
Plasmids were prepared from each selected transformant, digested with £coRI and screened
for the presence of the insert. Of 6 transformants selected from Clostridium sp. strain TN-
271 3 were found to contain an insert and 2 to contain an insert of the predicted size. Of 5
transformants selected from Eubacterium sp. strain 1-10 3 were found to contain an insert
and 2 to contain an insert of the predicted size. One transformant from each ligation
reaction was selected for further analysis. The results also show a 3.9 kb fragment which
corresponds to the vector (Fig. 4).
Southern blot Analysis.
The cloned 6a/G-like inserts from Clostridium sp. strain TN-271 and Eubacterium
sp. strain I-10 were used as probes to verify the bacterial strain of origin and to determine
if cross-hybridization would occur with Eubacterium sp. strain V.P.I. 12708 chromosome.
Figure 5 shows the Southern blotting results from Clostridium sp. strain TN-271,
Eubacterium sp. strain 1-10, and Eubacterium sp. strain V.P.I. 12708 chromosomes probed
with the baiG-likQ gene fragment of Clostridium sp. strain TN-271. Hybridization occurred
between the probe and the chromosomal DNA of Clostridium sp. strain TN-271 and
chromosomal DNA of Eubacterium sp. strain V.P.I. 12708.
Figure 6 shows the Southern blotting results from Eubacterium sp. strain I-10,
Clostridium sp. strain TN-271, and Eubacterium sp. strain V.P.I. 12708 probed with the
baiG-\ike gene fragment of Eubacterium sp. strain I-10. Hybridization occurred between the
probe and the chromosomal DNA of Eubacterium sp. strain 1-10.
19
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Figure 4. EcoRl restriction digest for screening of the plasmids prepared from E. coli
INVa F' cells transformed with baiG-like gene fragments ligated into pCR 2.1 vector.
Lane 7; molecular weight marker. Lanes 1-6 contain plasmids from Clostridium sp.
strain TN-271 baiG-like gene transformants and lanes 8-12 contain plasmids from
Eubacterium sp. strain I-10 baiG-like gene transformants.
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Figure 5. Autoradiogram of bacterial chromosomes (2 ug) probed with the baiG
gene fragment from Clostridium sp. strain TN-271. Equivalent quantities of DNA
(2 ug) from each were digested with EcoRl. Lane 1, Eubactehum sp. strain V.P.I.
12708; lane 2, Clostridium sp. strain TN-271; lane 3 Eubacterium sp. strain I-10.
21
Figure 6. Autoradiogram of bacterial chromosomes probed with the
gene fragment from Eubacterium sp. strain I-10. Equivalent quantities of DNA
from Clostridium sp. strain TN-271 and Eubacterium sp. strain I-10 were digested
with EcoRl. Lane 1, Eubacterium sp. strain V.P.I. 12708 ; lane 2, Clostridium sp.
strain TN-271; lane 3, Eubacterium sp. strain 1-10.
22
No cross-hybridization has been found between the probe and the chromosomal DNA of
Eubacterium sp. strain V.P.I. 12708.
DNA sequence analysis.
The results of the sequencing reactions for Clostridium sp. strain TN-271 using the
T7 promoter show 97% identity to Eubacterium sp. strain V.P.I. 12708 baiG gene (Table 2).
Results for the Eubacterium sp. strain I-10 DNA using the M-13 reverse primer show 96%
identity to Eubacterium sp. strain V.P.I. 12708 baiG gene (Table 2). The sequences
resulting from these reactions are shown in appendixes A and B.
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Table 2. DNA sequencing results of the baiG-like gene fragment of two bile acid 7a-
dehydroxylating bacterial strains and comparisons with the known nucleotide sequence of
Eubacterium sp. strain V.P.I. 12708 baiG gene.
Source of
baiG-Mke
gene
fragment
Clostridium
sp. strain
TN-271
Eubacterium
sp. strain
1-10
Size of Insert
364
364
DNA Sequencing Priming Site
T7 Promoter
# bases
sequenced
317
*
% identity
with baiG
97
*
Ml3 Reverse
# bases
sequenced
*
364
% identity
with baiG
*
96
* Indicates that sequence data was obtained
IV. DISCUSSION
Eubacterium sp. strain V.P.I. 12708 and the bile acid 7a-dehydroxylation pathway
have been studied intensely for several years. However, research focusing on other bacterial
strains capable of 7a-dehydroxylating bile acids is lacking. The baiG gene encodes a bile
acid transporter in Eubacterium sp. strain V.P.I. 12708 (19). The BaiG polypeptide is
crucial to the 7a-dehydroxylation pathway because the polypeptide transports the primary
bile acids into the cell.
To clone the Z>a/G-like gene from the selected bacterial strains PCR primers were
prepared that would amplify the baiG gene in Eubacterium sp. strain V.P.I. 12708. In order
for amplification to occur, in other strains of bile acid 7oc-dehydroxylating bacteria the
nucleotide sequences in the selected bacterial strains must be similar to the nucleotide
sequence of the baiG gene in Eubacterium sp. strain V.P.I. 12708. The PCR results showed
that only Eubacterium sp. strain V.P.I. 12708, Clostridium sp. strain TN-271, and
Eubacterium sp. strain I-10 produced an amplified product of the predicted size. These
results suggest that both Clostridium sp. strain TN-271 and Eubacterium sp. strain 1-10
contain baiG-like genes similar to the baiG gene found in Eubacterium sp. strain V.P.I.
12708. No amplified product was observed for Clostridium bifermentans strain 1-55,
Clostridium sordellii strain Y67, Clostridium sp. strain HD-17, and Clostridium sp. strain
TO-931.
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These results imply that Clostridium bifermentans strain 1-55, Clostridium sordellii
strain Y67, Clostridium sp. strain HD-17, and Clostridium sp. strain TO-931 do not contain
baiG-Xike genes or that these strains contain baiGAikz genes that do not hybridize to the
primers.
Sequencing reactions from both the 5' and 3' end of the inserts were performed for
both Clostridium sp. strain TN-271 and Eubacterium sp. strain I-10 baiGAxks, gene
fragments. However, successful sequencing reactions for Clostridium sp. strain TN-271
were obtained using only the T7 primer site and the Ml3 primer site for the Eubacterium
sp.strain 1-10 baiGAxke gene. Difficulties involving the sequencing reactions could be due
to lack of DNA stability during shipping. Sequencing homology between the amplified
fragments and the baiG gene in Eubacterium sp. strain V.P.I. 12708 was 96%-97%,
suggesting that a baiG-liks gene exists in both bacterial strains. These results are
encouraging; however in future studies primers that will enable the entire baiG-like genes
to be cloned and sequenced must be prepared. Cloning and sequencing of the complete
Z><2/G-like gene from Clostridium sp. strain TN-271 and Eubacterium sp. strain I-10 must be
performed to more throughly understand this gene.
hi the Southern blot reactions utilizing the baiG-Mke gene fragment of Clostridium
sp. strain TN-271 as a probe, hybridization occurred between Eubacterium sp. strain V.P.I.
12708 and Clostridium sp. strain TN-271 chromosome. These data further suggest that a
6a/G-like gene exists in Clostridium sp. strain TN-271 and is similar in sequence to the baiG
gene in Eubacterium sp. strain V.P.I. 12708.
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In the Southern blot reaction that used the baiG-like gene of Eubacterium sp. strain
I-10 as a probe, hybridization occurred with Eubacterium sp. strain I-10 chromosome and
no hybridization occurred with Eubacterium sp. strain V.P.I. 12708 chromosome. The lack
of hybridization with Eubacterium sp. strain V.P.I. 12708 could be due to less than optimal
hybridization conditions as regards to incubation temperature or an insufficient amount of
Eubacterium sp. strain V.P.I. 12708 chromosomal DNA.
Results of sequencing analysis and Southern blots suggest a baiG-like gene is located
in both Eubacterium sp. strain I-10 and Clostridium sp. strain TN-271. Previous studies (8)
have demonstrated that a baiG-like gene is present in Clostridium sp. strain TN-271. Thus,
with the 6a;G-like gene found in both Clostridium sp. strain TN-271 and Eubacterium sp.
strain I-10 these bacteria are also candidates for inducing gallstone formation in humans.
These results are significant because it has been estimated that in Western countries
cholesterol gall stone disease is prevalent in approximately 10% of the population, and
cholesterol gallstone disease costs Americans six billion dollars annually in health-care
expenditures. However, studies on bile acid 7a-dehydroxylating bacteria is lacking. Bile
acid 7a-dehydroxylating bacteria have not been directly implicated in causing colon
carcinogenesis, but secondary bile acids are co-carcinogens which stimulate tumor growth
(5). Research focusing on bile acid 7a-dehydroxylating bacteria is important and crucial in
establishing correlations between diseases such as cholesterol gallstone formation and colon
carcinogenesis with bile acid 7oc-dehydroxylating bacteria.
Appendix
CAGTTTGTTCCTGTGCATCCCATCCTTCGGACAGAACATCGGATGGTCTTCC
ACAGCATTTATCGGAGCTGCGGCAGTAGCGCTGGTGGCACTTTTCATCCTGGT
AATGGTAGAAAAGAAAGCGAAGAGTCCGATCATGAACGGCAAGTTTATGGCA
CGCAAGGAATTCGTGCTTCCAGTATTGATCCTATTCCTTACTCAGGGACTTATG
ATGGCAAATATGACCAATGTCATCGTGTTCGTGCGCTATACGCAGCCGGACAA
TGTCATTATATCAAGTTTTGCGATCTCCATCATGTACATAGGAATGTCTTTAGG
CTCCGTTATCATTGGAC (317nt)
Appendix A. Nucleic acid sequence of Clostridium sp. TN-271 Z»a/G-like gene fragment
insert using the 11 promotor as the primer site for the sequencing reaction. The Fl primer
is shown in bold.
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CGTCTTTGGCTCTTTCTTATCTGCAACAGGTCCAATGATAACGGAGCCTAAA
GACATTCCTATGTACATGATGGAGATCGCAAAACTTGATATAATGACATTGTC
CGGCTGCGTATAGCGCACGAACACGATGACATTGGTCATATTTGCCATCATAA
GTCCCTGAGTAAGGAATAGGATCAATACTGGAAGCACGAATTCCTTGCGTGCC
ATAAACTTGCCGTTCATGATCGGACTCTTCGCTTTCTTTTCATCCATTACCAGG
ATGAAAAGTGCCACCAGCGCTACTGCCGCAGCTCCGATAAATGCTGTGGAAGA
CCATCCGATGTTCTGTCCGAAGGATGGGGATGCACAGAAACAAACTGA
(364nt)
Appendix B. Nucleic acid sequence of Eubacteriwn sp. I-10 baiG gene fragment insert
using the Ml3 reverse promotor as the primer site for the sequencing reaction. The Bl
primer is shown in bold and the F1 primer is shown in bold and underlined.
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